38 0

The Efficacy of Pharmacological Treatment in Pediatric Nonalcoholic Fatty Liver Disease

Title
The Efficacy of Pharmacological Treatment in Pediatric Nonalcoholic Fatty Liver Disease
Author
백승삼
Keywords
Child; Nonalcoholic fatty liver disease; Vitamin E; Ursodeoxycholic acid; Pharmacotherapy
Issue Date
2012-12
Publisher
대한소아소화기영양학회
Citation
Pediatric gastroenterology, hepatology & nutrition, 2012, 15(4), P.256-265, 10P.
Abstract
Purpose: With growing number of obese children, the prevalence of nonalcoholic fatty liver disease (NAFLD) in pediatric population is increasing. Nonalcoholic steatohepatitis (NASH) is a severe form of NAFLD, and can cause morbid complications. It is important to identify patients in order to grade pathologic severities and treat those children who possibly have NASH. This study was performed to evaluate whether the pharmacological therapy is also effective as well as the body weight reduction in pediatric NAFLD. Methods: Among the 52 children presenting with obesity and hepatopathy, NAFLD was diagnosed through liver biopsy in 29 children, who were 7 to 14 years of age, from January 2006 to December 2011. The patients were advised to reduce their body weight through diverse methods. Medication with Ursodeoxycholic acid (UDCA) and vitamin E was performed in children whose liver functions did not improve or their weight reductions were not successful.The therapeutic effects were monitored and assessed via the biochemical profiles and the physical measurements.Results: The therapy of vitamin E and UDCA combined with body mass index (BMI) reduction showed significantly higher rate of improvement in clinical profiles, which could be seen in data of aspartate aminotransferase (AST), alanine aminotransferase (ALT), AST/ALT ratio, alkaline phosphatase, total bilirubin and γ-glutamyl transpeptidase. Children whose BMI were successfully reduced showed favorable clinical improvements without any medication,but those without BMI reduction did not show any improvement despite medications.Conclusion: This study showed that the first line of therapy should be the BMI reduction in NAFLD and drug therapy combined with BMI reduction could have additive therapeutic effect in children with NAFLD. (Pediatr Gastroenterol Hepatol Nutr 2012; 15: 256∼265)
URI
https://synapse.koreamed.org/DOIx.php?id=10.5223/pghn.2012.15.4.256http://hdl.handle.net/20.500.11754/50288
ISSN
2234-8840; 2234-8646
DOI
10.5223/pghn.2012.15.4.256
Appears in Collections:
COLLEGE OF MEDICINE[S](의과대학) > MEDICINE(의학과) > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE